This content is from: Patents
Eli Lilly counsel reflects on twists and turns of Alimta lawsuits
Ivan Burnside tells Managing IP how the pemetrexed case on salt substitution shook up European patent law
To access our in-house intelligence please request a trial here.
Read this article – and more – for a 30 day period.
REQUEST ACCESSAre you already an Managing IP subscriber? Login here